APPLICATIONS PUBLISHED 10 NOVEMBER 2004
Published: 2-Jun-2005
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Anti-microbial compsn comprising a metal ion chelating agent
Aq+ 1474101*
Thickeners for use in surfactant-containing formulations
Beiersdorf 1474102*
Levothyroxine compsns and methods
King Pharmaceuticals 1474103*
Demixing-stable granulate
Sandoz 1474104*
Medicated tampon
Kimberley-Clark Worldwide 1473105*
Efficient liposomal encapsulation under mild conditions
Elan Pharmaceuticals 1474107*
Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds
Enzrel 1474108*
Use of synthetic organic or inorganic nanoparticles as carriers for ophthalmic and otic drugs
Alcon 1474109*
Depot medicament, carrier materials for depot medicaments, and method for the production thereof
Deutsche Gelatine-Fabriken Stoess 1474110*
Sterile lyophilised ifsoamide and associated methods
American Pharmaceutical Partners 1474111*
Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
Pliva-Istrazivacki Institut 1474112*
Edible PGA coating compsn
FMC Corp 1474113*
Oral dosage form for controlled drug release
Glaxo Group 1474114*
Non-gelatine capsule shell formulation comprising iota-carragenan and kappa-carrageenan
Banner Pharmacaps 1474115*
Colonic release compsn
Allzyme Therapeutics 1474116*
Compsn for inhalation
AstraZeneca 1474117*
Compsn for inhalation
AstraZeneca 1474118*
Use of extracts containing phytoestrogen electively modulating estrogen-receptor-beta
AstraZeneca 1474119*
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of the same in the detection and treatment of cancer. viral infection and autoimmune disease
Technion Research and Development Foundation 1474120*
Small molecule antagonists of BCL2 family proteins
The Regents of the University of Michigan 1474121*
Compounds for blocking androgen receptors
Trident Sciences 1474122*
Controlled release pharmaceutical formulation containing venlafaxine
LEK Pharmaceuticals 1474123*
Active ingredient for producing a substance containing isocitrate for influencing the coagulation of blood
responsif GmbH 1474124*
The use of omega-3 polyunsaturated fatty acids ethyl esters in patients suffering from heart failure
Victorix Assets 1474125*
Treatments for neurotoxicity in Alzheimer's disease
Massachusetts Institute of Technology; Whitehead Institute for Biomedical Research 1474126*
Biphenyl derivatives and their use as anti-androgenic agents
Endorecherche 1474127*
S-dimethylarsino-thiosuccinic acid, S-dimethylarsino-2-thiobenzoic acid, S-dimethylarsino-glutathione as treatments for cancer
Board of Regents The University of Texas System; The Texas A&M University System 1474128*
Use of genistein in the manufacture of a medicament for the treatment of osteoporosis and obesity, and compsns containing genistein in combination with vitamins D and K
N. V. Nutrica 1474129*
Use of compounds and compsns derived from olives for protecting cells against DNA damage
Lavipharm 1474130*
Use of anethole dithiolethione in lung cancer chemoprevention
Solvay Pharma 1474131*
Histamine-3 receptor ligands for diabetic conditions
Abbott Laboratories 1474132*
Crystalline solids of carvediol, and processes for their preparation
Teva Pharmaceuticals 1474133*
Combination preparation of the sodium-hydrogen exchange inhibitor cariporide with ACE inhibitors for preventing heart failure and other age-related dysfunctions of organs, age-related diseases and for prolonging lifespan
Aventis Pharma 1474134*
Indole, azaindole and related heterocyclic pyrrolidine derivatives
Bristol-Myers Squibb 1474135*
Use of indole-3-acetic acids in the treatment of asthma, COPD and other diseases
AstraZeneca 1474136*
Use of indole-3-acetic acids in the treatment of asthma, COPD and other diseases
AstraZeneca 1474137*
Microglia inhibitors for interrupting immune reactions induced by interleukin 12 and IFN-g
Schering 1474138*
11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidaemia
Merck 1474139*
2-oxazolamines and their use as 5-HT2B receptor antagonists
Pharmagene Laboratories 1474140*
5-HT2B receptor antagonists
Pharmagene Laboratories 1474141*
Preparations containing folic acid, vitamin B6, and vitamin B12, and use thereof
Synavit GmbH 1474142*
Methods and compsns for treating male erectile dysfunction
Modular Properties 1474143*
Controlled release pharmaceutical dosage forms of a cholesterol ester transfer protein inhibitor
Pfizer Products 1474144*
Quinoline derivatives as NPY antagonists
F Hoffmann-La Roche 1474145*
Phenylpyridine amines as IGE inhibitors
Novartis 1474146*
Pyrimidine-based compounds useful as GSK-3 inhibitors
Vertex Pharmaceuticals 1474147*
Treatment of neuroblastoma
Novartis 1474148*
Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
Boehringer Ingelheim Pharma 1474149*
Use of 2-alkoxyphenyl-substituted imidazotriazinones
Bayer HealthCare 1474150*
Methods of treatment of chronic immune disease
RED Laboratories 1474151*
Orodispersible pharmaceutical compsn comprising ivabradine
Les Laboratoires Servier 1474152*
Methods for particle-assisted polynucleotide immunisation using a pulsed electric field
Genetronics 1474153*
Improvements in or relating to compsns
Reckitt Benckiser Healthcare (UK) 1474154*
Method of treatment of gastrointestinal disease and polymeric compsn for use therein
Chemeq 1474155*
Materials from bone marrow stromal cells for use in forming blood vessels and producing angiogenic and trophic factors
Henry Ford Health System 1474156*
Compsns based on plant extracts for lowering and retaining blood sugar levels
Szabo, Zsuzsanna 1474157*
Prevention and treatment of oxidative stress disorders by glutathione and phase II detoxification enzymes
Brassica Development for Chemoprotection Research 1474158*
Compsns containing oat straw and willowherb extract
Johnson & Johnson 1474159*
Personal care compsn containing leghaemoglobin
Arch Personal Care Products 1474160*
Engineered binding proteins
Zyomyx 1474161*
Methods and compsns for the treatment of eye diseases
Merck Patent 1474162*
Modification of feeding behaviour
Imperial College Innovations; Oregon Health & Science University 1474163*
Use of amylin agonists to modulate triglycerides
Amylin Pharmaceuticals 1474164*
Thermotolerant phytase for animal feed
Syngenta Participations 1474165*
Ehrlichia disulfide bond formation proteins and uses thereof
Research Development Foundation 1474166*
Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
University of Maryland 1474167*
7S immunoglobulin for treatment of choroidal neovascularisation
Brunner, Rochard 1474168*
Means and methods for altering the motility of the gastrointestinal tract
Academisch Medisch Centrum bij de Universiteit van Amsterdam 1474169*
Method for reducing acne or improving skin tone
Johnson & Johnson Consumer Companies 1474170*
Weight management system for obese animals
Mars Inc 1474171*
Pharmaceutical compsn for hepatitis C viral protease inhibitors
Boehringer Ingelheim Pharma 1474172*
Compsn and methods for protecting labile active components
Arch Personal Care Products 1474173*
Compsn for oral or rectal administration
LTP Lipid Technologies 1474174*
Agents that regulate apoptosis
Immusol 1474175*
Novel human G-protein coupled receptor, HGPRBMY31, and variants and methods of use thereof
Bristol-Myers Squibb 1474176*
Non-invasive diagnostic imaging technology for mitochondria using radiolabelled lipophilic salts
The Johns Hopkins University 1474177*
Benzothiazole derivatives for in vivo imaging of amyloid plaques
Amersham; Hammersmith Imanet 1474178*
